Literature DB >> 17665763

Pre-anaesthetic screening of geriatric dogs.

K E Joubert1.   

Abstract

Pre-anaesthetic screening has been advocated as a valuable tool for improving anaesthetic safety and determining anaesthetic risk. This study was done determine whether pre-anaesthetic screening result in cancellation of anaesthesia and the diagnosis of new clinical conditions in geriatric dogs. One hundred and one dogs older than 7 years of age provided informed owner consent were included in the study. Each dog was weighed, and its temperature, pulse and respiration recorded. An abdominal palpation, examination of the mouth, including capillary refill time and mucous membranes, auscultation, body condition and habitus was performed and assessed. A cephalic catheter was placed and blood drawn for pre-anaesthetic testing. A micro-haematocrit tube was filled and the packed cell volume determined. The blood placed was in a test tube, centrifuged and then analysed on an in-house blood analyser. Alkaline phosphatase, alanine transferase, urea, creatinine, glucose and total protein were determined. A urine sample was then obtained by cystocentesis, catheterisation or free-flow for analysis. The urine specific gravity was determined with a refractometer. A small quantity of urine was then placed on a dip stick. Any new diagnoses made during the pre-anaesthetic screening were recorded. The average age of the dogs was 10.99 +/- 2.44 years and the weight was 19.64 +/- 15.78 kg. There were 13 dogs with pre-existing medical conditions. A total of 30 new diagnoses were made on the basis of the pre-anaesthetic screening. The most common conditions were neoplasia, chronic kidney disease and Cushing's disease. Of the 30 patients with a new diagnosis, 13 did not undergo anaesthesia as result of the new diagnosis. From this study it can be concluded that screening of geriatric patients is important and that sub-clinical disease could be present in nearly 30 % of these patients. The value of screening before anaesthesia is perhaps more questionable in terms of anaesthetic practice but it is an appropriate time to perform such an evaluation. The value of pre-anaesthetic screening in veterinary anaesthesia still needs to be evaluated in terms of appropriate outcome variables.

Entities:  

Mesh:

Year:  2007        PMID: 17665763     DOI: 10.4102/jsava.v78i1.283

Source DB:  PubMed          Journal:  J S Afr Vet Assoc        ISSN: 1019-9128            Impact factor:   1.474


  6 in total

1.  Ultrasonographic and laboratory screening in clinically normal mature golden retriever dogs.

Authors:  Jinelle A Webb; Gordon M Kirby; Stephanie G Nykamp; Meredith J Gauthier
Journal:  Can Vet J       Date:  2012-06       Impact factor: 1.008

2.  Effect of routine pre-anesthetic laboratory screening on pre-operative anesthesia-related decision-making in healthy dogs.

Authors:  Krista Mitchell; Michele Barletta; Jane Quandt; Molly Shepard; Stephanie Kleine; Erik Hofmeister
Journal:  Can Vet J       Date:  2018-07       Impact factor: 1.008

3.  Effect of screening abdominal ultrasound examination on the decision to pursue advanced diagnostic tests and treatment in dogs with neurologic disease.

Authors:  N M Tong; A L Zwingenberger; W H Blair; S L Taylor; R X Chen; B K Sturges
Journal:  J Vet Intern Med       Date:  2015-04-21       Impact factor: 3.333

4.  Results of Screening of Apparently Healthy Senior and Geriatric Dogs.

Authors:  A Willems; D Paepe; S Marynissen; P Smets; I Van de Maele; P Picavet; L Duchateau; S Daminet
Journal:  J Vet Intern Med       Date:  2016-10-17       Impact factor: 3.333

5.  Geriatric screening in first opinion practice - results from 45 dogs.

Authors:  M Davies
Journal:  J Small Anim Pract       Date:  2012-07-27       Impact factor: 1.522

6.  Management of veterinary anaesthesia in small animals: A survey of current practice in Quebec.

Authors:  Geoffrey Truchetti; Colombe Otis; Anne-Claire Brisville; Guy Beauchamp; Daniel Pang; Eric Troncy
Journal:  PLoS One       Date:  2020-01-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.